A BILL 
To rescue domestic medical manufacturing activity by pro-
viding incentives in economically distressed areas of the 
United States and its possessions. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Medical Manufac-
4
turing, Economic Development, and Sustainability Act of 
5
2021’’ or the ‘‘MMEDS Act of 2021’’. 
6
04:45 Jun 02, 2021
H2653
2 
•HR 2653 IH
SEC. 2. ECONOMICALLY DISTRESSED ZONES. 
1
(a) IN GENERAL.—Chapter 1 of the Internal Rev-
2
enue Code of 1986 is amended by adding at the end the 
3
following new subchapter: 
4
‘‘Subchapter AA—Medical Manufacturing in 
5
Economically Distressed Zones 
6
‘‘SUBCHAPTER AA—MEDICAL MANUFACTURING IN ECONOMICALLY DISTRESSED 
ZONES 
‘‘Sec. 1400AA–1. Medical manufacturing in economically distressed zone credit. 
‘‘Sec. 1400AA–2. Credit for economically distressed zone products and services 
acquired by domestic medical manufacturers. 
‘‘Sec. 1400AA–3. Special rules to secure the national supply chain and for the 
production of population health products. 
‘‘Sec. 1400AA–4. Designation of economically distressed zones. 
‘‘SEC. 1400AA–1. MEDICAL MANUFACTURING IN ECONOMI-
7
CALLY DISTRESSED ZONE CREDIT. 
8
‘‘(a) ALLOWANCE OF CREDIT.—There shall be al-
9
lowed as a credit against the tax imposed by subtitle A 
10
for the taxable year an amount equal 40 percent of the 
11
sum of— 
12
‘‘(1) the aggregate amount of the taxpayer’s 
13
medical manufacturing economically distressed zone 
14
wages for such taxable year, 
15
‘‘(2) the allocable employee fringe benefit ex-
16
penses of the taxpayer for such taxable year, and 
17
‘‘(3) the depreciation and amortization allow-
18
ances of the taxpayer for the taxable year with re-
19
spect to qualified medical manufacturing facility 
20
property. 
21
04:45 Jun 02, 2021
H2653
3 
•HR 2653 IH
‘‘(b) DENIAL OF DOUBLE BENEFIT.—Any wages or 
1
other expenses taken into account in determining the cred-
2
it under this section may not be taken into account in de-
3
termining the credit under sections 41, and any other pro-
4
vision determined by the Secretary to be substantially 
5
similar. 
6
‘‘(c) DEFINITIONS AND SPECIAL RULES.—For pur-
7
poses of this section— 
8
‘‘(1) 
ECONOMICALLY
DISTRESSED
ZONE 
9
WAGES.— 
10
‘‘(A) IN
GENERAL.—The term ‘economi-
11
cally distressed zone wages’ means amounts 
12
paid or incurred for wages of an employee by 
13
the taxpayer for the taxable year which are— 
14
‘‘(i) in connection with the active con-
15
duct of a trade or business of the taxpayer, 
16
and 
17
‘‘(ii) paid or incurred for an employee 
18
the principal place of employment of whom 
19
is in a qualified medical manufacturing fa-
20
cility of such taxpayer. 
21
‘‘(B) LIMITATION ON AMOUNT OF WAGES 
22
TAKEN INTO ACCOUNT.— 
23
‘‘(i) IN
GENERAL.—The amount of 
24
wages which may be taken into account 
25
04:45 Jun 02, 2021
H2653
4 
•HR 2653 IH
under subparagraph (A) with respect to 
1
any employee for any taxable year shall 
2
not exceed the contribution and benefit 
3
base determined under section 230 of the 
4
Social Security Act for the calendar year 
5
in which such taxable year begins. 
6
‘‘(ii) TREATMENT OF PART-TIME EM-
7
PLOYEES, ETC.—If— 
8
‘‘(I) any employee is not em-
9
ployed by the taxpayer on a substan-
10
tially full-time basis at all times dur-
11
ing the taxable year, or 
12
‘‘(II) the principal place of em-
13
ployment of any employee is not with-
14
in an economically distressed zone at 
15
all times during the taxable year, 
16
the limitation applicable under clause (i) 
17
with respect to such employee shall be the 
18
appropriate portion (as determined by the 
19
Secretary) of the limitation which would 
20
otherwise be in effect under clause (i). 
21
‘‘(C) TREATMENT
OF
CERTAIN
EMPLOY-
22
EES.—The term ‘economically distressed zone 
23
wages’ shall not include any wages paid to em-
24
ployees who are assigned by the employer to 
25
04:45 Jun 02, 2021
H2653
5 
•HR 2653 IH
perform services for another person, unless the 
1
principal trade or business of the employer is to 
2
make employees available for temporary periods 
3
to other persons in return for compensation. 
4
‘‘(D) WAGES.—For purposes of this para-
5
graph, the term ‘wages’ shall not include any 
6
amounts which are allocable employee fringe 
7
benefit expenses. 
8
‘‘(2) ALLOCABLE EMPLOYEE FRINGE BENEFIT 
9
EXPENSES.— 
10
‘‘(A) IN
GENERAL.—The term ‘allocable 
11
employee fringe benefit expenses’ means the ag-
12
gregate amount allowable as a deduction under 
13
this chapter to the taxpayer for the taxable year 
14
for the following amounts which are allocable to 
15
employment in a qualified medical manufac-
16
turing facility and which are not included as 
17
economically distressed zone wages pursuant to 
18
this subsection: 
19
‘‘(i) Employer contributions under a 
20
stock bonus, pension, profit-sharing, or an-
21
nuity plan. 
22
‘‘(ii) 
Employer-provided 
coverage 
23
under any accident or health plan for em-
24
ployees. 
25
04:45 Jun 02, 2021
H2653
6 
•HR 2653 IH
‘‘(iii) The cost of life or disability in-
1
surance provided to employees. 
2
‘‘(B) ALLOCATION.—For purposes of sub-
3
paragraph (A), an amount shall be treated as 
4
allocable to a qualified medical manufacturing 
5
facility only if such amount is with respect to 
6
employment of an individual for services pro-
7
vided, and the principal place of employment of 
8
whom is, in such facility. 
9
‘‘(3) QUALIFIED MEDICAL MANUFACTURING FA-
10
CILITY.—The term ‘qualified medical manufacturing 
11
facility’ means any facility that— 
12
‘‘(A) researches and develops or produces 
13
medical products or essential components of 
14
medical products, and 
15
‘‘(B) is located within an economically dis-
16
tressed zone. 
17
‘‘(4) QUALIFIED MEDICAL MANUFACTURING FA-
18
CILITY
PROPERTY.—The term ‘qualified medical 
19
manufacturing facility property’ means any property 
20
used in (or consisting of) a qualified medical manu-
21
facturing facility if such property is directly con-
22
nected to the research, development, or production 
23
of a medical product. 
24
04:45 Jun 02, 2021
H2653
7 
•HR 2653 IH
‘‘(5) MEDICAL
PRODUCT; ESSENTIAL
COMPO-
1
NENT.— 
2
‘‘(A) MEDICAL PRODUCT.—The term ‘med-
3
ical product’ means— 
4
‘‘(i) a drug that— 
5
‘‘(I) is a prescription drug sub-
6
ject to regulation under section 505 of 
7
the Federal Food, Drug, and Cos-
8
metic Act (21 U.S.C. 355) or section 
9
351 of the Public Health Service Act 
10
(42 U.S.C. 262), 
11
‘‘(II) is subject to regulation 
12
under section 802 of the Federal 
13
Food, Drug, and Cosmetic Act (21 
14
U.S.C. 382), or 
15
‘‘(III) is described in section 
16
201(jj) of such Act (21 U.S.C. 
17
321(jj)), or 
18
‘‘(ii) a device, as defined in section 
19
201(h) of such Act (21 U.S.C. 321(h)). 
20
‘‘(B) ESSENTIAL COMPONENT.—The term 
21
‘essential component’ means, with respect to a 
22
medical product— 
23
‘‘(i) an active pharmaceutical ingre-
24
dient, or 
25
04:45 Jun 02, 2021
H2653
8 
•HR 2653 IH
‘‘(ii) a protein, antibody, enzyme, hor-
1
mone, or other organic material that is an 
2
active ingredient in a biological product. 
3
‘‘(6) AGGREGATION RULES.— 
4
‘‘(A) IN GENERAL.—For purposes of this 
5
section, members of an affiliated group shall be 
6
treated as a single taxpayer. 
7
‘‘(B) AFFILIATED GROUP.—The term ‘af-
8
filiated group’ means an affiliated group (as de-
9
fined in section 1504(a), determined without re-
10
gard to section 1504(b)(3)) one or more mem-
11
bers of which are engaged in the active conduct 
12
of a trade or business within an economically 
13
distressed zone. 
14
‘‘SEC. 1400AA–2. CREDIT FOR ECONOMICALLY DISTRESSED 
15
ZONE PRODUCTS AND SERVICES ACQUIRED 
16
BY DOMESTIC MEDICAL MANUFACTURERS. 
17
‘‘(a) ALLOWANCE OF CREDIT.—In the case of an eli-
18
gible medical manufacturer, there shall be allowed as a 
19
credit against the tax imposed by subtitle A for the taxable 
20
year an amount equal to the applicable percentage of the 
21
aggregate amounts paid or incurred by the taxpayer dur-
22
ing such taxable year for qualified economically distressed 
23
zone products or services. 
24
04:45 Jun 02, 2021
H2653
9 
•HR 2653 IH
‘‘(b) APPLICABLE PERCENTAGE.—For purposes of 
1
this section, the term applicable percentage means— 
2
‘‘(1) 30 percent in the case of amounts paid or 
3
incurred to persons not described in paragraph (2) 
4
or (3), 
5
‘‘(2) 40 percent in the case of amounts paid or 
6
incurred to an unrelated minority business, and 
7
‘‘(3) 5 percent in the case of amounts paid or 
8
incurred to a related person. 
9
‘‘(c) ELIGIBLE
MEDICAL
MANUFACTURER.—For 
10
purposes of this section, the term ‘eligible medical manu-
11
facturer’ means any person in the trade or business of pro-
12
ducing medical products in the United States. 
13
‘‘(d) QUALIFIED PRODUCT OR SERVICE.—For pur-
14
poses of this section, the term ‘qualified product or service’ 
15
means— 
16
‘‘(1) any product which is produced in an eco-
17
nomically distressed zone and which is integrated 
18
into a medical product produced by the taxpayer, 
19
and 
20
‘‘(2) any service which is provided in an eco-
21
nomically distressed zone and which is necessary to 
22
the production of a medical product by the taxpayer 
23
(including packaging). 
24
04:45 Jun 02, 2021
H2653
10 
•HR 2653 IH
‘‘(e) MINORITY BUSINESS.—For purposes of this sec-
1
tion— 
2
‘‘(1) IN GENERAL.—The term ‘minority busi-
3
ness’ means— 
4
‘‘(A) a sole proprietorship carried on by a 
5
qualified individual, or 
6
‘‘(B) a corporation or partnership— 
7
‘‘(i) at least 50 percent of the owner-
8
ship interests in which are held by one or 
9
more qualified individuals, and 
10
‘‘(ii) of which a qualified individual is 
11
the president or chief executive officer (or 
12
a substantially equivalent position). 
13
‘‘(2) QUALIFIED INDIVIDUAL.—The term ‘quali-
14
fied individual’ means any individual who— 
15
‘‘(A) is of Asian-Indian, Asian-Pacific, 
16
Black, Hispanic, or Native American origin or 
17
descent, and 
18
‘‘(B) is a United States citizen or legal 
19
resident of the United States or any of its terri-
20
tories or possessions. 
21
‘‘(f) RELATED PERSONS.—For purposes of this sec-
22
tion, persons shall be treated as related to each other if 
23
such persons would be treated as a single employer under 
24
the regulations prescribed under section 52(b). 
25
04:45 Jun 02, 2021
H2653
11 
•HR 2653 IH
‘‘(g) OTHER TERMS.—Terms used in this section 
1
which are also used in section 1400AA–1 shall have the 
2
same meaning as when used in such section. 
3
‘‘SEC. 1400AA–3. SPECIAL RULES TO SECURE THE NATIONAL 
4
SUPPLY CHAIN AND FOR THE PRODUCTION 
5
OF POPULATION HEALTH PRODUCTS. 
6
‘‘(a) IN GENERAL.—In the case of a qualified repatri-
7
ated medical manufacturing facility or a qualified popu-
8
lation health product manufacturing facility— 
9
‘‘(1) section 1400AA–1(a) shall be applied by 
10
substituting ‘60 percent’ for ‘40 percent’, and 
11
‘‘(2) section 1400AA–2(a) shall be applied— 
12
‘‘(A) by substituting ‘50 percent’ for ‘30 
13
percent’, and 
14
‘‘(B) by substituting ‘60 percent’ for ‘40 
15
percent’. 
16
‘‘(b) ELECTION TO EXPENSE IN LIEU OF TAX CRED-
17
IT FOR DEPRECIATION.—In the case of a taxpayer which 
18
elects (at such time and in such manner as the Secretary 
19
may provide) the application of this subsection with re-
20
spect to any qualified repatriated medical manufacturing 
21
facility or qualified population health product manufac-
22
turing facility— 
23
04:45 Jun 02, 2021
H2653
12 
•HR 2653 IH
‘‘(1) section 1400AA–1(a)(3) shall not apply 
1
with respect to any qualified medical manufacturing 
2
facility property with respect to such facility, and 
3
‘‘(2) for purposes of section 168(k)— 
4
‘‘(A) such property shall be treated as 
5
qualified property, and 
6
‘‘(B) the applicable percentage with respect 
7
to such property shall be 100 percent. 
8
‘‘(c) QUALIFIED REPATRIATED MEDICAL MANUFAC-
9
TURING FACILITY.—For purposes of this section, the term 
10
‘qualified repatriated medical manufacturing facility’ 
11
means any qualified medical manufacturing facility (as de-
12
fined in section 1400AA–1) the production of which was 
13
moved to an economically distressed zone from a foreign 
14
country that the United States Trade Representative has 
15
determined could pose a risk to the national supply chain 
16
because of political or social factors. 
17
‘‘(d) QUALIFIED POPULATION HEALTH PRODUCT 
18
MANUFACTURING FACILITY.—For purposes of this sec-
19
tion, the term ‘qualified population health product manu-
20
facturing facility’ means any qualified medical manufac-
21
turing facility (as defined in section 1400AA–1) that pro-
22
duces a population health product (as defined in section 
23
319L(a)(11) of the Public Health Service Act) which the 
24
Secretary of Health and Human Services has identified 
25
04:45 Jun 02, 2021
H2653
13 
•HR 2653 IH
for support through a strategic initiative under section 
1
319L(c)(4)(F)(ii) of the Public Health Service Act. 
2
‘‘SEC. 1400AA–4. DESIGNATION OF ECONOMICALLY DIS-
3
TRESSED ZONES. 
4
‘‘(a) IN GENERAL.—For purposes of this subchapter, 
5
the term ‘economically distressed zone’ means any popu-
6
lation census tract within the United States which— 
7
‘‘(1) has a poverty rate of not less than 35 per-
8
cent for each of the 5 most recent calendar years for 
9
which information is available, or 
10
‘‘(2) satisfies each of the following require-
11
ments: 
12
‘‘(A) has pervasive poverty, unemployment, 
13
low labor force participation, and general dis-
14
tress measured as a prolonged period of eco-
15
nomic decline measured by real gross national 
16
product, 
17
‘‘(B) has a poverty rate of not less than 30 
18
percent for each of the 5 most recent calendar 
19
years for which information is available, and 
20
‘‘(C) has been designated as such by the 
21
Secretary and the Secretary of Commerce pur-
22
suant to an application under subsection (b). 
23
‘‘(b) APPLICATION FOR DESIGNATION.— 
24
04:45 Jun 02, 2021
H2653
14 
•HR 2653 IH
‘‘(1) IN GENERAL.—An application for designa-
1
tion as an economically distressed zone may be filed 
2
by a State or local government in which the popu-
3
lation census tract to which the application applies 
4
is located. 
5
‘‘(2) REQUIREMENTS.—Such application shall 
6
include a strategic plan for accomplishing the pur-
7
poses of this subchapter, which— 
8
‘‘(A) describes the coordinated economic, 
9
human, community, and physical development 
10
plan and related activities proposed for the 
11
nominated area, 
12
‘‘(B) describes the process by which the af-
13
fected community is a full partner in the proc-
14
ess of developing and implementing the plan 
15
and the extent to which local institutions and 
16
organizations have contributed to the planning 
17
process, 
18
‘‘(C) identifies the amount of State, local, 
19
and private resources that will be available in 
20
the nominated area and the private/public part-
21
nerships to be used, which may include partici-
22
pation by, and cooperation with, universities, 
23
medical centers, and other private and public 
24
entities, 
25
04:45 Jun 02, 2021
H2653
15 
•HR 2653 IH
‘‘(D) identifies the funding requested 
1
under any Federal program in support of the 
2
proposed economic, human, community, and 
3
physical development and related activities, 
4
‘‘(E) identifies baselines, methods, and 
5
benchmarks for measuring the success of car-
6
rying out the strategic plan, including the ex-
7
tent to which poor persons and families will be 
8
empowered to become economically self-suffi-
9
cient, and 
10
‘‘(F) does not include any action to assist 
11
any establishment in relocating from one area 
12
outside the nominated area to the nominated 
13
area, except that assistance for the expansion of 
14
an existing business entity through the estab-
15
lishment of a new branch, affiliate, or sub-
16
sidiary is permitted if— 
17
‘‘(i) the establishment of the new 
18
branch, affiliate, or subsidiary will not re-
19
sult in a decrease in employment in the 
20
area of original location or in any other 
21
area where the existing business entity 
22
conducts business operations, 
23
‘‘(ii) there is no reason to believe that 
24
the new branch, affiliate, or subsidiary is 
25
04:45 Jun 02, 2021
H2653
16 
•HR 2653 IH
being established with the intention of clos-
1
ing down the operations of the existing 
2
business entity in the area of its original 
3
location or in any other area where the ex-
4
isting business entity conducts business op-
5
eration, and 
6
‘‘(iii) includes such other information 
7
as may be required by the Secretary and 
8
the Secretary of Commerce. 
9
‘‘(c) PERIOD FOR WHICH DESIGNATIONS ARE IN EF-
10
FECT.—Designation as an economically distressed zone 
11
may be made at any time during the 10-year period begin-
12
ning on the date of the enactment of this section, and shall 
13
remain in effect with respect to such zone during the 15- 
14
year period beginning on the date of such designation. 
15
Economically distressed zones described in subsection 
16
(a)(1) shall take effect on the date of the enactment of 
17
this Act and shall remain in effect during the 15-year pe-
18
riod beginning on such date. 
19
‘‘(d) TERRITORIES
AND POSSESSIONS.—The term 
20
‘United States’ includes the 50 States, the District of Co-
21
lumbia, and the territories and possessions of the United 
22
States. 
23
‘‘(e) REGULATIONS.—The Secretary shall issue such 
24
regulations or other guidance as may be necessary or ap-
25
04:45 Jun 02, 2021
H2653
17 
•HR 2653 IH
propriate to carry out the purposes of this section, includ-
1
ing— 
2
‘‘(1) not later than 30 days after the date of 
3
the enactment of this section, a list of the population 
4
census tracts described in subsection (a)(1), and 
5
‘‘(2) not later than 60 days after the date of 
6
the enactment of this section, regulations or other 
7
guidance regarding the designation of population 
8
census tracts described in subsection (a)(2).’’. 
9
(b) EFFECTIVE DATE.—The amendments made by 
10
this section shall apply to taxable years beginning after 
11
December 31, 2020. 
12
SEC. 3. AUTHORITY TO SUPPORT DEVELOPMENT OF POPU-
13
LATION HEALTH PRODUCTS. 
14
(a) DEFINITIONS.— 
15
(1) QUALIFIED
COUNTERMEASURE.—Subpara-
16
graph (A) of section 319F–1(a)(2) of the Public 
17
Health Service Act (42 U.S.C. 247d–6a(a)(2)) is 
18
amended to read as follows: 
19
‘‘(A) QUALIFIED COUNTERMEASURE.—The 
20
term ‘qualified countermeasure’ means a drug 
21
(as that term is defined by section 201(g)(1) of 
22
the Federal Food, Drug, and Cosmetic Act (21 
23
U.S.C. 321(g)(1))), biological product (as that 
24
term is defined by section 351(i) of this Act (42 
25
04:45 Jun 02, 2021
H2653
18 
•HR 2653 IH
U.S.C. 262(i))), or device (as that term is de-
1
fined by section 201(h) of the Federal Food, 
2
Drug, and Cosmetic Act (21 U.S.C. 321(h))), 
3
that the Secretary determines to be a priority 
4
consistent with sections 302(2) and 304(a) of 
5
the Homeland Security Act of 2002— 
6
‘‘(i) to diagnose, mitigate, prevent, or 
7
treat harm from any biological agent (in-
8
cluding organisms that cause an infectious 
9
disease), toxin, chemical, radiological, or 
10
nuclear agent that may cause a public 
11
health emergency affecting national secu-
12
rity; or 
13
‘‘(ii) to diagnose, mitigate, prevent, or 
14
treat harm from an underlying non-com-
15
municable disease which, combined with 
16
pandemic influenza or an emerging infec-
17
tious disease, may result in adverse health 
18
consequences or serious threat to one or 
19
more vulnerable American populations (as 
20
defined in section 319L(a)) in an epidemic 
21
or pandemic.’’. 
22
(2) OTHER
DEFINITIONS.—Subsection (a) of 
23
section 319L of the Public Health Service Act (42 
24
04:45 Jun 02, 2021
H2653
19 
•HR 2653 IH
U.S.C. 247d–7e) is amended by adding at the end 
1
the following new paragraphs: 
2
‘‘(11) POPULATION
HEALTH
PRODUCT.—The 
3
term ‘population health product’ means a widely 
4
available drug to diagnose, mitigate, prevent, or 
5
treat harm from an underlying non-communicable 
6
disease which, combined with pandemic influenza or 
7
an emerging infectious disease, may result in ad-
8
verse health consequences or a serious threat to one 
9
or more vulnerable American populations in an epi-
10
demic or pandemic. 
11
‘‘(12) 
VULNERABLE
AMERICAN
12
LATIONS.—The term ‘vulnerable American popu-
13
lations’ means children, pregnant women, older 
14
adults, minority populations, and other at-risk indi-
15
viduals with relevant characteristics that warrant 
16
consideration during the process of researching and 
17
developing such countermeasures and products.’’. 
18
(b) STRATEGIC INITIATIVES.—Clause (ii) of section 
19
319L(c)(4)(F) of the Public Health Service Act (42 
20
U.S.C. 247d–7e(c)(4)(F)) is amended to read as follows: 
21
‘‘(ii) threats that consistently exist or 
22
continually circulate and have a significant 
23
potential to become a pandemic, such as 
24
pandemic influenza and emerging infec-
25
04:45 Jun 02, 2021
H2653
20 
•HR 2653 IH
tious diseases in combination with under-
1
lying non-communicable diseases, which 
2
may include the advanced research and de-
3
velopment, manufacturing, and appropriate 
4
stockpiling of qualified pandemic or epi-
5
demic products, and products, technologies, 
6
or processes to support the advanced re-
7
search and development of such counter-
8
measures (including multiuse platform 
9
technologies for diagnostics, vaccines, and 
10
therapeutics; virus seeds; clinical trial lots; 
11
novel virus strains; and antigen and adju-
12
vant material); and’’. 
13
(c) AT-RISK INDIVIDUALS.—Paragraph (6) of section 
14
319L(c) of the Public Health Service Act (42 U.S.C. 
15
247d–7e(c)) is amended to read as follows: 
16
‘‘(6) AT-RISK
INDIVIDUALS.—In carrying out 
17
the functions under this section, the Secretary may 
18
give a priority to advanced research and develop-
19
ment of— 
20
‘‘(A) qualified countermeasures and quali-
21
fied pandemic or epidemic products likely to be 
22
safe and effective with respect to vulnerable 
23
American populations; and 
24
04:45 Jun 02, 2021
H2653
21 
•HR 2653 IH
‘‘(B) population health products likely to 
1
protect vulnerable American populations with 
2
underlying non-communicable diseases from dis-
3
proportionate 
harm 
in 
epidemics 
and 
4
pandemics.’’. 
5
(d) OTHER AUTHORITIES.—Section 319L(c) of the 
6
Public Health Service Act (42 U.S.C. 247d–7e(c)) is 
7
amended by adding at the end the following: 
8
‘‘(8) 
TIMELY
DELIVERY
OF
9
HEALTH PRODUCTS TO AT-RISK INDIVIDUALS.—The 
10
Secretary shall collaborate with the Administrator of 
11
the Centers for Medicare & Medicaid Services, the 
12
Secretary of Defense, the Secretary of Veterans Af-
13
fairs, the Commissioner of Food and Drugs, and the 
14
heads of other Federal agencies involved with ap-
15
proval and distribution of health products to assure 
16
that such Federal agencies distribute approved pop-
17
ulation health products as promptly and effectively 
18
as possible, and as continuously as possible, to pro-
19
tect vulnerable American populations from harm in 
20
epidemics and pandemics. 
21
‘‘(9) REPORT ON NEED FOR INCENTIVIZING DE-
22
VELOPMENT OF POPULATION HEALTH PRODUCTS.— 
23
Not later than 90 days after the date of enactment 
24
of the Medical Manufacturing, Economic Develop-
25
04:45 Jun 02, 2021
H2653
22 
•HR 2653 IH
ment, and Sustainability Act of 2021, the Secretary 
1
shall examine and report to the Congress on— 
2
‘‘(A) the extent to which the health of 
3
aging Americans, African Americans, His-
4
panics, Native Americans, veterans, or other 
5
vulnerable American populations has been dis-
6
proportionately harmed by the COVID–19 pan-
7
demic and prior epidemics and pandemics; 
8
‘‘(B) the population health products cur-
9
rently available and whether there is a need for 
10
additional 
innovation 
and 
development 
to 
11
produce population health products to reduce 
12
the exposure of vulnerable American popu-
13
lations to risk of disproportionate harm in 
14
epidemics and pandemics; and 
15
‘‘(C) whether the Secretary recommends 
16
providing the same incentives for the develop-
17
ment and marketing of population health prod-
18
ucts as is given with respect to covered infec-
19
tious disease products under the Federal Food, 
20
Drug, and Cosmetic Act, including under sec-
21
tion 505E of such Act.’’. 
22
Æ 
04:45 Jun 02, 2021
H2653
